Partnership with NHS
“We look forward to continuing our partnership with C-POLAR™ Biotech Limited in order to expand our manufacturing capability to increase the supply to both public and private sectors in the near future.”
​
Anthony J Robson
Managing Director
QE Facilities Limited
Part of the Gateshead Health NHSFT Group
C-POLAR™ Filter
C-POLAR™ is the world’s first energy-free and non-toxic technology to arrest and eliminate 99.9% of COVID-19. The new technology became the first air filtration invention from Hong Kong to receive an exemption from the U.S. Environmental Protection Agency (EPA) and approval from the U.K. National Health Server (NHS) since the outbreak of the COVID-19 pandemic.
When used as the air filter, it is proven that the new bioelectret material can bring us a safer and cleaner indoor environment to ensure a healthcare setting.
​
C-POLAR™ Filter has been deployed in over 100 buildings in Hong Kong including the Tallest Building International Commerce Centre (ICC)
​
Studies have shown C-POLAR™ to
Arrest: the negative charged virus or bacteria is captured by C-POLAR™’s positive polarity and arrested upon contact.
Inactivate: the negative charged protective envelop is inactivated as the C-POLAR™ tears away the envelope exposing the virus or bacteria’s protein.
Eliminate: the protein structure is then disintegrated.